IL-18 inhibits cytotoxic cells to regulate alveolar septal destruction and airway fibrosis, and, notably, IL-18-induced progression of pulmonary fibrosis was alleviated in the absence of BRP-39, a downstream effector of IL-18 [146]. Here, IL18 is linked to pulmonary fibrosis.